| Literature DB >> 28507526 |
Anni Richter1, Adriana Barman1, Torsten Wüstenberg2, Joram Soch1, Denny Schanze3, Anna Deibele1, Gusalija Behnisch1, Anne Assmann1,4, Marieke Klein1, Martin Zenker3, Constanze Seidenbecher1,5, Björn H Schott1,2,4,5.
Abstract
Dopamine is critically important in the neural manifestation of motivated behavior, and alterations in the human dopaminergic system have been implicated in the etiology of motivation-related psychiatric disorders, most prominently addiction. Patients with chronic addiction exhibit reduced dopamine D2 receptor (DRD2) availability in the striatum, and the DRD2 TaqIA (rs1800497) and C957T (rs6277) genetic polymorphisms have previously been linked to individual differences in striatal dopamine metabolism and clinical risk for alcohol and nicotine dependence. Here, we investigated the hypothesis that the variants of these polymorphisms would show increased reward-related memory formation, which has previously been shown to jointly engage the mesolimbic dopaminergic system and the hippocampus, as a potential intermediate phenotype for addiction memory. To this end, we performed functional magnetic resonance imaging (fMRI) in 62 young, healthy individuals genotyped for DRD2 TaqIA and C957T variants. Participants performed an incentive delay task, followed by a recognition memory task 24 h later. We observed effects of both genotypes on the overall recognition performance with carriers of low-expressing variants, namely TaqIA A1 carriers and C957T C homozygotes, showing better performance than the other genotype groups. In addition to the better memory performance, C957T C homozygotes also exhibited a response bias for cues predicting monetary reward. At the neural level, the C957T polymorphism was associated with a genotype-related modulation of right hippocampal and striatal fMRI responses predictive of subsequent recognition confidence for reward-predicting items. Our results indicate that genetic variations associated with DRD2 expression affect explicit memory, specifically for rewarded stimuli. We suggest that the relatively better memory for rewarded stimuli in carriers of low-expressing DRD2 variants may reflect an intermediate phenotype of addiction memory.Entities:
Keywords: C957T; TaqIA; dopamine D2 receptor; episodic memory; fMRI; intermediate phenotype; reward
Year: 2017 PMID: 28507526 PMCID: PMC5410587 DOI: 10.3389/fpsyg.2017.00654
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Demographic data and behavioral data of the memory parameters regarding TaqIA polymorphism.
| TaqIA | A1+ | A2A2 | Statistics |
|---|---|---|---|
| Women/Men | 16/15 | 14/17 | χ2 = 0.26, |
| Mean age | 25.1 ± 3.3 | 24.0 ± 2.0 | |
| AQ | 14.9 ± 7.0 | 15.4 ± 7.1 | |
| C957T CC/CT/TT | 12/19/0 | 3/16/12 | χ2 = 17.66, |
| COMT MM/VM/VV | 6/22/3 | 8/14/9 | χ2 = 5.06, |
| RASGRF1 GG/TG/TT | 11/13/7 | 9/17/5 | χ2 = 1.07, |
| DAT1 10-10/10-09/11-09 | 20/10/1 | 19/12/0 | χ2 = 1.21, |
| Smoking status (no/yes) | 19/11 | 26/5 | χ2 = 3.32, |
| Corrected hit rates – monetary condition | |||
| Neutral [%] | 20.45 ± 12.50 | 20.26 ± 11.28 | Main effect of TaqIA |
| Reward [%] | 19.61 ± 12.06 | 15.61 ± 10.90 | genotype |
| Corrected hit rates – social condition | |||
| Neutral [%] | 18.97 ± 14.18 | 18.45 ± 10.45 | η2 = 0.05 |
| Reward [%] | 24.06 ± 14.32 | 18.19 ± 12.21 | |
| Familiarity estimates – monetary condition | |||
| Neutral | 0.46 ± 0.35 | 0.39 ± 0.27 | Main effect of TaqIA |
| Reward | 0.45 ± 0.29 | 0.32 ± 0.26 | genotype |
| Familiarity estimates – social condition | |||
| Neutral | 0.44 ± 0.39 | 0.39 ± 0.32 | η2 = 0.06 |
| Reward | 0.43 ± 0.34 | 0.38 ± 0.32 | |
| Median confidence ratings – monetary condition | |||
| Neutral | 3.50 | 3.50 | Interaction of TaqIA |
| Reward | 3.00 | 3.25 | genotype × trial type × |
| Median confidence ratings – social condition | reward category | ||
| Neutral | 3.50 | 3.50 | |
| Reward | 3.50 | 3.50 | η2 = 0.05 |
Demographic data and behavioral data of the memory parameters regarding C957T polymorphism.
| C957T | CC | CT | TT | |
|---|---|---|---|---|
| Women/men | 9/6 | 18/17 | 3/9 | χ2 = 3.57, |
| Mean age | 23.9 ± 2.3 | 25.1 ± 3.1 | 23.9 ± 1.8 | |
| AQ | 15.6 ± 6.6 | 15.3 ± 7.6 | 14.2 ± 5.7 | χ2 = 0.21, |
| COMT MM/VM/VV | 3/10/2 | 7/22/6 | 4/4/4 | χ2 = 3.94, |
| RASGRF1 GG/TG/TT | 3/6/6 | 15/17/3 | 2/7/3 | χ2 = 8.89, |
| DAT1 10-10/10-09/11-09 | 10/4/1 | 23/12/0 | 6/6/0 | χ2 = 4.58, |
| Smoking status (no/yes) | 12/2 | 23/12 | 10/2 | χ2 = 2.77, |
| Corrected hit rates – monetary condition | ||||
| Neutral [%] | 23.67 ± 11.68 | 18.69 ± 12.25 | 19.83 ± 10.04 | Main effect of C957T |
| Reward [%] | 20.13 ± 12.18 | 18.69 ± 10.98 | 11.33 ± 11.26 | genotype |
| Corrected hit rates – social condition | ||||
| Neutral [%] | 23.73 ± 12.58 | 17.49 ± 12.51 | 16.00 ± 10.69 | η2 = 0.13 |
| Reward [%] | 26.27 ± 19.73 | 21.20 ± 9.61 | 14.50 ± 12.24 | |
| Familiarity estimates – monetary condition | ||||
| Neutral | 0.58 ± 0.33 | 0.35 ± 0.32 | 0.42 ± 0.21 | Main effect of C957T |
| Reward | 0.43 ± 0.33 | 0.40 ± 0.27 | 0.30 ± 0.26 | genotype |
| Familiarity estimates – social condition | ||||
| Neutral | 0.55 ± 0.44 | 0.35 ± 0.30 | 0.42 ± 0.36 | η2 = 0.12 |
| Reward | 0.55 ± 0.45 | 0.39 ± 0.28 | 0.27 ± 0.25 | |
| Median confidence ratings – monetary condition | ||||
| Neutral | 3.50 | 3.50 | 3.00 | Interaction of C957T |
| Reward | 3.00 | 3.00 | 3.50 | genotype × trial type × |
| Median confidence ratings – social condition | reward category | |||
| Neutral | 3.50 | 3.50 | 3.75 | |
| Reward | 3.00 | 3.50 | 3.50 | η2 = 0.13 |
Demographic data and behavioral data of the memory parameters regarding the TaqIA/C957T haplotype.
| Haplotype | A1+/C+ | A1-/C+ | A1-/C- | |
|---|---|---|---|---|
| Women/men | 16/15 | 11/8 | 3/9 | χ2 = 3.45, |
| Mean age | 25.1 ± 3.3 | 24.1 ± 2.1 | 23.9 ± 1.8 | |
| AQ | 14.9 ± 7.0 | 16.1 ± 7.9 | 14.2 ± 5.7 | χ2 = 0.28, |
| COMT MM/VM/VV | 6/22/3 | 4/10/5 | 4/4/4 | χ2 = 6.21, |
| RASGRF1 GG/TG/TT | 11/13/7 | 7/10/2 | 2/7/3 | χ2 = 2.84, |
| DAT1 10-10/10-09/11-09 | 20/10/1 | 13/6/0 | 6/6/0 | χ2 = 2.31, |
| Smoking status (no/yes) | 19/11 | 16/3 | 10/2 | χ2 = 3.33, |
| Corrected hit rates – monetary condition | ||||
| Neutral [%] | 20.45 ± 12.50 | 20.53 ± 12.25 | 19.83 ± 10.04 | Main effect of |
| Reward [%] | 19.61 ± 12.06 | 18.32 ± 10.03 | 11.33 ± 11.26 | haplotype |
| Corrected hit rates – social condition | ||||
| Neutral [%] | 18.97 ± 14.12 | 20.00 ± 10.29 | 16.00 ± 10.69 | η2 = 0.10 |
| Reward [%] | 24.06 ± 14.32 | 20.53 ± 11.92 | 14.50 ± 12.24 | |
| Familiarity estimates – monetary condition | ||||
| Neutral | 0.46 ± 0.35 | 0.37 ± 0.31 | 0.42 ± 0.21 | Main effect of |
| Reward | 0.45 ± 0.29 | 0.34 ± 0.27 | 0.30 ± 0.26 | haplotype |
| Familiarity estimates – social cndition | ||||
| Neutral | 0.44 ± 0.39 | 0.37 ± 0.29 | 0.42 ± 0.36 | η2 = 0.07 |
| Reward | 0.43 ± 0.34 | 0.45 ± 0.35 | 0.27 ± 0.25 | |
| Median confidence ratings – monetary condition | ||||
| Neutral | 3.50 | 3.50 | 3.00 | Interaction of |
| Reward | 3.00 | 3.00 | 3.50 | haplotype × trial type × |
| Median confidence ratings – social condition | reward category | |||
| Neutral | 3.50 | 3.50 | 3.75 | |
| Reward | 3.50 | 3.00 | 3.50 | η2 = 0.14 |